{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:54:19Z","timestamp":1791230059268,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ejps.2010.09.009","type":"journal-article","created":{"date-parts":[[2010,9,24]],"date-time":"2010-09-24T10:33:46Z","timestamp":1285324426000},"page":"665-669","source":"Crossref","is-referenced-by-count":16,"title":["Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG"],"prefix":"10.1016","volume":"41","author":[{"given":"Zo\u00e1rd Tibor","family":"Krasznai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Mikecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Fodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Galuska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Hern\u00e1di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2010.09.009_bib0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0006-2952(00)00341-5","article-title":"Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP\/MXR\/ABCP on the transport of (99m)Tc-tetrofosmin","volume":"60","author":"Chen","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2010.09.009_bib0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.bjc.6604523","article-title":"[18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study","volume":"99","author":"Direcks","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejps.2010.09.009_bib0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3816\/CBC.2007.n.035","article-title":"The role of efflux pumps in drug-resistant metastatic breast cancer: new insights and treatment strategies","volume":"7","author":"Fojo","year":"2007","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.ejps.2010.09.009_bib0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1567201043480036","article-title":"The role of ABC transporters in drug resistance, metabolism and toxicity","volume":"1","author":"Glavinas","year":"2004","journal-title":"Curr. Drug. Deliv."},{"key":"10.1016\/j.ejps.2010.09.009_bib0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1124\/jpet.106.110155","article-title":"Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody","volume":"320","author":"Goda","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2010.09.009_bib0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/156800909788166493","article-title":"Multidrug resistance through the spectacle of P-glycoprotein","volume":"9","author":"Goda","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejps.2010.09.009_bib0035","first-page":"235","article-title":"Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution","volume":"27","author":"Hamacher","year":"1986","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2010.09.009_bib0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006231-200401000-00004","article-title":"P-glycoprotein expression is associated with FDG uptake and cell differentiation in patients with untreated lung cancer","volume":"25","author":"Higashi","year":"2004","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.ejps.2010.09.009_bib0045","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/clpt.2009.138","article-title":"Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications","volume":"86","author":"Kannan","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2010.09.009_bib0050","first-page":"1021","article-title":"Influence of the heterogeneity of P-glycoprotein expression on technetium-99m-MIBI uptake in breast cancer","volume":"39","author":"Kostakoglu","year":"1998","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2010.09.009_bib0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejps.2006.02.006","article-title":"Paclitaxel modifies the accumulation of tumor-diagnostic tracers in different ways in P-glycoprotein-positive and negative cancer cells","volume":"28","author":"Krasznai","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2010.09.009_bib0060","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.nucmedbio.2005.04.014","article-title":"Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin","volume":"32","author":"Liu","year":"2005","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejps.2010.09.009_bib0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0006-2952(86)90221-2","article-title":"Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell lines","volume":"35","author":"Louie","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2010.09.009_bib0070","doi-asserted-by":"crossref","first-page":"18132","DOI":"10.1074\/jbc.M210413200","article-title":"Allosteric modulation of human P-glycoprotein. Inhibition of transport by preventing substrate translocation and dissociation","volume":"278","author":"Maki","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2010.09.009_bib0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/srao.2001.18100","article-title":"Positron-emission tomographic imaging of cancer: glucose metabolism and beyond","volume":"11","author":"Mankoff","year":"2001","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.ejps.2010.09.009_bib0080","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00259-003-1204-3","article-title":"In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance","volume":"30","author":"M\u00e1ri\u00e1n","year":"2003","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejps.2010.09.009_bib0085","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bjp.0702807","article-title":"The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein","volume":"128","author":"Martin","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2010.09.009_bib0090","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1073\/pnas.89.13.5824","article-title":"Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody","volume":"89","author":"Mechetner","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2010.09.009_bib0095","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1073\/pnas.94.24.12908","article-title":"P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity","volume":"94","author":"Mechetner","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2010.09.009_bib0100","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1046\/j.1432-1327.2001.02122.x","article-title":"P-glycoprotein conformational changes detected by antibody competition","volume":"268","author":"Nagy","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejps.2010.09.009_bib0105","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bbrc.2004.01.156","article-title":"Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies","volume":"315","author":"Nagy","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2010.09.009_bib0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0969-8051(97)00226-6","article-title":"FDG accumulation and tumor biology","volume":"25","author":"Pauwels","year":"1998","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejps.2010.09.009_bib0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/BST0330241","article-title":"ABC transporters in the balance: is there a role in multidrug resistance?","volume":"33","author":"Polg\u00e1r","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejps.2010.09.009_bib0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1148\/radiol.2312021185","article-title":"Clinical applications of PET in oncology","volume":"231","author":"Rohren","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.ejps.2010.09.009_bib0125","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/S0021-9258(18)53221-X","article-title":"Human P-glycoprotein transports cyclosporine A and FK506","volume":"268","author":"Saeki","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2010.09.009_bib0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.1432-1327.1998.2510252.x","article-title":"A general pattern for substrate recognition by P-glycoprotein","volume":"251","author":"Seelig","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejps.2010.09.009_bib0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0928-0987(00)00177-9","article-title":"Structure\u2013activity relationship of P-glycoprotein substrates and modifiers","volume":"12","author":"Seelig","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2010.09.009_bib0140","first-page":"1303","article-title":"P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro","volume":"34","author":"Seo","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejps.2010.09.009_bib0145","first-page":"1038","article-title":"Targeting glucose transporters for tumor imaging: \u201csweet\u201d idea, \u201csour\u201d result","volume":"37","author":"Wahl","year":"1996","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2010.09.009_bib0150","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jnci\/89.7.512","article-title":"Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives and MRK-16 antibodies","volume":"89","author":"Watanabe","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejps.2010.09.009_bib0155","first-page":"983","article-title":"Use of PET for monitoring cancer therapy and for predicting outcome","volume":"46","author":"Weber","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2010.09.009_bib0160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1346-8138.2005.tb00904.x","article-title":"Factors influencing [F-18] 2-fluoro-2-deoxy-d-glucose (F-18 FDG) accumulation in melanoma cells: Is FDG a substrate of multidrug resistance (MDR)?","volume":"32","author":"Yamada","year":"2005","journal-title":"J. Dermatol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098710003210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098710003210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T15:30:52Z","timestamp":1636558252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098710003210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0928098710003210"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2010.09.009","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}